Company Filing History:

8 out of 379

University of Louisville Research Foundation, Inc

patents

3 out of 7

Advanced Cancer Therapeutics, LLC

patents

1 out of 4

Antisoma Research Limited

patents

Years Active: 2008-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12116592 - Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs) (2024-10-15),

2. 11072777 - Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs) (2021-07-27),

3. 10370665 - Compositions and methods for treating cancer, inhibiting cell proliferation, and inducing cell death (2019-08-06),

4. 8648051 - Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin (2014-02-11),

5. 8586717 - Method for the diagnosis and prognosis of malignant diseases (2013-11-19),

6. 8410070 - Compositions and methods for treating cancer, inhibiting proliferation, and inducing cell death (2013-04-02),

7. 8114850 - Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin (2012-02-14),

8. 8029784 - Method for the diagnosis and prognosis of malignant diseases (2011-10-04),

9. 7960540 - Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin (2011-06-14),

10. 7541150 - Method for the diagnosis and prognosis of malignant diseases (2009-06-02),

11. 7357928 - Method for the diagnosis and prognosis of malignant diseases (2008-04-15),

12. 7314926 - Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin (2008-01-01),

Title: Innovations of Donald Miller in Stem Cell Research

Introduction

Donald Miller is a prominent inventor based in Louisville, KY (US), known for his significant contributions to the field of regenerative medicine. With a total of 12 patents to his name, Miller has focused on advancing methods for the ex vivo expansion of very small embryonic-like stem cells (VSELs). His work has the potential to revolutionize treatments for various medical conditions.

Latest Patents

Miller's latest patents include innovative methods and compositions for the ex vivo expansion of VSELs. These methods allow for the growth of VSELs in a culture medium that contains a histone deacetylase inhibitor, luteinizing hormone, follicle-stimulating hormone, and optionally transforming growth factor beta. This approach is designed to overcome the quiescence of VSELs, enabling their use in various therapeutic applications. The patents also cover feeder cell-free cell cultures, pharmaceutical compositions, and methods for treating injuries to tissues, repopulating cell types, and bone marrow transplantation.

Career Highlights

Throughout his career, Donald Miller has worked with notable organizations such as the University of Louisville Research Foundation, Inc. and Advanced Cancer Therapeutics, LLC. His research has contributed to the understanding and application of stem cell technology in regenerative medicine.

Collaborations

Miller has collaborated with esteemed colleagues, including Paula J Bates and John Olaf Trent, to further his research and innovations in the field.

Conclusion

Donald Miller's work in stem cell research exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of advancing scientific knowledge for therapeutic purposes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com